VenritidineAlternative Names: D 16637
Latest Information Update: 28 Nov 1997
At a glance
- Originator Unknown
- Developer Helopharm
- Class Antihistamines
- Mechanism of Action Histamine H2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Gastric ulcer
Most Recent Events
- 28 Nov 1997 No-Development-Reported for Gastric ulcer in United Kingdom (Unknown route)
- 28 Nov 1997 No-Development-Reported for Gastric ulcer in Germany (Unknown route)